Relmada Therapeutics to Participate at the Jefferies Global Healthcare Conference in London

Relmada Therapeutics Inc. (RLMD) — CORAL GABLES, Fla., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology and central nervous system disorders, today announced that Sergio Traversa, Chief Executive Officer, and Maged Shenouda, Chief Financial Officer, will participate in the Jefferies Global Healthcare Conference being held in London, UK, from November 16 - 19, 2026. Jefferies Global Healthcare

Source: GlobeNewswire — read the full announcement there.

See our Relmada Therapeutics company profile for background, links, and more Relmada Therapeutics news.